Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

July 19, 2022

Primary Completion Date

July 17, 2024

Study Completion Date

November 30, 2027

Conditions
Diffuse Large B Cell Lymphoma
Interventions
DRUG

Tafasitamab

tafasitamab will be administered intravenously at protocol defined timepoints

DRUG

Lenalidomide

lenalidomide will be administered orally at protocol defined timepoints

Trial Locations (62)

3100

UK St. Pölten, Sankt Pölten

4600

Klinikum Wels Grieskirchen, Wels

4763

Hanyang University Medical Center, Seoul

5020

Universitatsklinikum Salzburg, Salzburg

5505

Asan Medical Center - PPDS, Seoul

6122

Azienda Ospedaliera di Perugia, Perugia

7198

Hospital Son Llatzer, Palma de Mallorca

7345

The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul

8907

ICO l'Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat

10060

Fondazione del Piemonte per l'Oncologia (IRCCS), Candiolo

13100

ZIV Medical Center, Safed

16247

The Catholic University of Korea, St. Vincent's Hospital, Suwon

17007

Institut Catala d'Oncologia Girona, Girona

20122

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan

20162

ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda, Milan

20900

ASST di Monza - Azienda Ospedaliera San Gerardo, Monza

21565

Gachon University Gil Medical Center, Incheon

27100

Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia

28031

Hospital U. Infanta Leonor, Madrid

28033

MD Anderson Madrid, Madrid

28034

Hospital U. Ramon y Cajal, Madrid

28040

Hospital Universitario Fundacion Jimenez Diaz, Madrid

28223

Hospital U. Quironsalud Madrid, Madrid

34362

Lady Davis Carmel Medical Center, Haifa

37007

Complejo Asistencial Universitario de Salamanca - H. Clinico, Salamanca

38043

Centre Hospitalier Universitaire Grenoble Alpes - Hopital Albert Michallon, Grenoble

41013

Hospital U. Virgen del Rocio, Seville

42415

Yeungnam University Hospital, Daegu

42472

Daegu Catholic University Medical Center, Daegu

44000

CHU Nantes, Nantes

44033

Ulsan University Hospital, Ulsan

46026

Hospital Universitari La Fe, Valencia

48121

Ospedale Santa Maria Delle Croci, Ravenna

49201

Dong-A University Medical Center, Busan

49241

Pusan National University Hospital, Busan

49267

Kosin University Gospel Hospital, Busan

54907

Chonbuk National University Hospital, Jeonju

56127

Azienda Ospedaliero Universitaria Pisana, Pisa

70300

Shamir Medical Center Assaf Harofeh, Be’er Ya‘aqov

72000

Centre Hospitalier Le Mans, Le Mans

84101

Soroka University Medical Centre, Beersheba

86021

CHU de Poitiers, Poitiers

91120

Hadassah Medical Center - Hadassah Ein Kerem, Jerusalem

98506

Vista Oncology, Olympia

07960-6459

Morristown Memorial Hospital, Morristown

75246-2092

Texas Oncology-Baylor Charles A. Sammons Cancer Center - USOR, Dallas

625 00

Fakultni nemocnice Brno, Brno

708 52

Fakultni nemocnice Ostrava, Ostrava

100 34

Fakultni nemocnice Kralovske Vinohrady, Prague

128 08

Vseobecna Fakultni Nemocnice V Praze, Prague

150 06

Fakultni nemocnice v Motole, Prague

60-185

Centrum Medyczne Poznan - PRATIA - PPDS, Skórzewo

30-510

Pratia MCM Krakow, Krakow

50-367

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu, Wroclaw

53-439

Dolnoslaskie Centrum Onkologii, Pulmonologii i Hematologii, Wroclaw

02-781

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warsaw

45-061

Szpital Wojewodzki w Opolu, Opole

81-519

Szpitale Pomorskie Sp. z o. o., Gdynia

31-501

SP ZOZ Szpital Uniwersytecki w Krakowie, Krakow

93-513

Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Lodz

10-228

SPZOZ MiSWiA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie, Olsztyn

87-100

Nasz Lekarz Osrodek Badan Klinicznych, Torun

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY